Article
Pharmacological reactivation of p53 in the era of precision anticancer medicine - Nature Reviews Clinical Oncology
Rating:
0.0
Views:
26
Likes:
1
Library:
1
p53, which is encoded by the most frequently mutated gene in cancer, TP53, is an attractive target for novel cancer therapies. Despite major challenges associated with this approach, several compounds that either augment the activity of wild-type p53 or restore all, or some, of the wild-type functions to p53 mutants are currently being explored.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value